You are here

AstraZeneca

AstraZeneca's Fasenra spares asthma patients from steroid use in large trial

AstraZeneca's Fasenra spares asthma patients from steroid use in large trial

Fierce Pharma

clinical trials

Flag link:

Enhertu picks up another win for AstraZeneca and Daiichi Sankyo, joining the priority review lane for gastric cancer

Enhertu picks up another win for AstraZeneca and Daiichi Sankyo, joining the priority review lane for gastric cancer

Endpoints

breakthrough status

metastatic gastric cancer

Flag link:

AstraZeneca's COVID-19 Vaccine Boosts Immune Response in Older, Younger Adults

AstraZeneca's COVID-19 Vaccine Boosts Immune Response in Older, Younger Adults

BioSpace

clinical trials

Flag link:

AstraZeneca resumes US COVID-19 vaccine trial; expects results later this year

AstraZeneca resumes US COVID-19 vaccine trial; expects results later this year

Biopharma Reporter

clinical trials

Flag link:

KSQ boosts PARP inhibition in animal models of ovarian and breast cancers with USP1 inhibitor

KSQ boosts PARP inhibition in animal models of ovarian and breast cancers with USP1 inhibitor

Fierce Biotech

KSQ Therapeutics

PARP inhibitors

Flag link:

[video+transcript]What Are the Differences Between the Leading Coronavirus Vaccine Candidates?

[video+transcript]What Are the Differences Between the Leading Coronavirus Vaccine Candidates?

Motley Fool

Moderna Therapeutics

Flag link:

2 Late-Stage Coronavirus Vaccine Candidates in Limbo

2 Late-Stage Coronavirus Vaccine Candidates in Limbo

Motley Fool

clinical trials

Flag link:

AstraZeneca Shares Drop Following Report of a COVID-19 Vaccine Study Patient Death in Brazil

AstraZeneca Shares Drop Following Report of a COVID-19 Vaccine Study Patient Death in Brazil

BioSpace

clinical trials

Flag link:

U.S. Trial With AstraZeneca's Coronavirus Vaccine Expected to Resume Soon

U.S. Trial With AstraZeneca's Coronavirus Vaccine Expected to Resume Soon

Motley Fool

clinical trials

Flag link:

COVID-19 vaccine biotech Vaccitech nabs Pfizer, Kite vet as full-time CMO

COVID-19 vaccine biotech Vaccitech nabs Pfizer, Kite vet as full-time CMO

Fierce Biotech

Flag link:

Moderna Works With International Regulators to Speed Up COVID-19 Vaccine Review Process

Moderna Works With International Regulators to Speed Up COVID-19 Vaccine Review Process

BioSpace

Moderna Therapeutics

Flag link:

AstraZeneca Secures $486 Million From U.S. Government for Coronavirus Antibody Cocktail

AstraZeneca Secures $486 Million From U.S. Government for Coronavirus Antibody Cocktail

Motley Fool

Flag link:

AstraZeneca puts a time limit on its COVID-19 'no-profit' pledge: report

AstraZeneca puts a time limit on its COVID-19 'no-profit' pledge: report

Fierce Pharma

Flag link:

Expect Pfizer/BioNTech and Moderna Coronavirus Vaccine Data Readouts in November-December, U.S. Vaccine Program Head Says

Expect Pfizer/BioNTech and Moderna Coronavirus Vaccine Data Readouts in November-December, U.S. Vaccine Program Head Says

Motley Fool

Operation Warp Speed

Moderna Therapeutics

clinical trials

Flag link:

As AstraZeneca’s Covid-19 vaccine trial remains on hold in U.S., participants waiting on a second dose are in limbo

As AstraZeneca’s Covid-19 vaccine trial remains on hold in U.S., participants waiting on a second dose are in limbo

Stat

clinical trials

Flag link:

AstraZeneca's Coronavirus Vaccine Is Already Being Reviewed for Approval in Canada and Europe. Why Not in the U.S.?

AstraZeneca's Coronavirus Vaccine Is Already Being Reviewed for Approval in Canada and Europe. Why Not in the U.S.?

Motley Fool

Flag link:

Nvidia to build the UK’s fastest supercomputer for AI drug-hunters at GSK, AstraZeneca and more

Nvidia to build the UK’s fastest supercomputer for AI drug-hunters at GSK, AstraZeneca and more

Fierce Biotech

artificial intelligence

Flag link:

The FDA hands Farxiga 'breakthrough' status in CKD, clearing path for AstraZeneca's much-touted therapy

The FDA hands Farxiga 'breakthrough' status in CKD, clearing path for AstraZeneca's much-touted therapy

Endpoints

chronic kidney disease

breakthrough therapy

Flag link:

AstraZeneca restarts another coronavirus vaccine trial, but US delay lingers

AstraZeneca restarts another coronavirus vaccine trial, but US delay lingers

BioPharma Dive

clinical trials

Flag link:

Go or no go? Vaccine panel upstages US approval decisions

Go or no go? Vaccine panel upstages US approval decisions

EP Vantage

Kala Pharmaceuticals

dry eye disease

Flag link:

Pages